VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NHC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
NHCNational HealthCare Corporation
$208.85$3.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNHCFinancials

National HealthCare Corporation (NHC) Income Statement

30Y historyFree accessUpdated daily

Revenue growth accelerated to 8.8% YoY in 2026Q2, with gross margin expanding to 40.7% and operating income surging 43.4% YoY, though net income includes significant investment gains that may overstate core profitability.

Income StatementBalance SheetCash FlowRatios

NHC Income Statement

Annual statement

NHC Income Statement

National HealthCare Corporation (NHC) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue1.58B1.52B1.3B1.14B1.07B1.01B980.71M996.38M980.35M963.89M923.58M906.62M871.68M788.96M761M773.24M720.65M668.22M633.21M598.03M562.96M542.38M521.83M472.86M458.25M419.97M462.42M440.14M441.2M463.48M386.3M
Revenue Growth %5.58%16.94%13.7%6.26%6.27%3.08%-1.57%1.64%1.71%4.37%1.87%4.01%10.49%3.67%-1.58%7.3%7.85%5.53%5.88%6.23%3.79%3.94%10.36%3.19%9.12%-9.18%5.06%-0.24%-4.81%19.98%10.56%
Cost of Goods Sold1.08B921.08M810.93M712.34M686.17M666.06M609.31M592.83M582.72M572.04M548.01M532.74M510.25M453.56M426.93M428.67M400.27M558.85M538.51M502.09M157.66M150.16M149.56M129.72M127.05M111.72M119.59M121.35M163.5M140M123.3M
COGS % of Revenue-60.69%62.48%62.4%63.87%65.89%62.13%59.5%59.44%59.35%59.34%58.76%58.54%57.49%56.1%55.44%55.54%83.63%85.05%83.96%28.01%27.69%28.66%27.43%27.72%26.6%25.86%27.57%37.06%30.21%31.92%
Gross Profit506.77M596.7M487.01M429.2M388.11M344.88M371.41M403.55M397.63M391.85M375.57M373.89M361.43M335.4M334.07M344.57M320.38M109.37M94.7M95.94M405.29M392.22M372.27M343.15M331.21M308.25M342.83M318.8M277.7M323.48M263M
Gross Margin %31.99%39.31%37.52%37.6%36.13%34.11%37.87%40.5%40.56%40.65%40.66%41.24%41.46%42.51%43.9%44.56%44.46%16.37%14.95%16.04%71.99%72.31%71.34%72.57%72.28%73.4%74.14%72.43%62.94%69.79%68.08%
Gross Profit Growth %-22.52%13.47%10.59%12.54%-7.14%-7.97%1.49%1.47%4.33%0.45%3.45%7.76%0.4%-3.05%7.55%192.94%15.49%-1.3%-76.33%3.33%5.36%8.49%3.61%7.45%-10.09%7.54%14.8%-14.15%23%8.5%
Operating Expenses351.84M468.35M401.25M372.07M356.22M293.95M323.25M354.51M341.55M337.74M315.03M306.76M293.42M263.32M265.83M265.72M262.76M58.5M57.14M57.21M357.34M343M330.91M307.78M292.32M280.93M318.79M299.41M255.4M273.3M222.8M
OpEx % of Revenue-30.86%30.91%32.59%33.16%29.08%32.96%35.58%34.84%35.04%34.11%33.84%33.66%33.38%34.93%34.36%36.46%8.75%9.02%9.57%63.48%63.24%63.41%65.09%63.79%66.89%68.94%68.02%57.89%58.97%57.68%
Selling, General & Admin35.37M46.23M43.18M41.52M40.98M40.82M40.49M40.52M40.92M40.37M41.29M39.97M39.73M39.45M39.35M39.74M38.09M32.35M31.45M40.2M343.17M327.54M317.15M295.4M279.95M268.2M304.35M289.02M243.3M258.3M209.6M
SG&A % of Revenue-3.05%3.33%3.64%3.81%4.04%4.13%4.07%4.17%4.19%4.47%4.41%4.56%5%5.17%5.14%5.28%4.84%4.97%6.72%60.96%60.39%60.78%62.47%61.09%63.86%65.82%65.67%55.15%55.73%54.26%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses3M422.12M358.06M330.54M315.24M253.14M282.76M314M300.63M297.38M273.74M266.79M253.69M223.87M226.48M225.98M224.67M26.14M25.69M17.01M14.17M15.46M13.77M12.38M12.37M12.73M14.44M10.38M12.1M15M13.2M
Operating Income154.94M128.35M85.76M57.13M31.9M50.92M48.16M49.04M56.08M54.11M60.54M67.13M68.01M72.08M68.24M78.85M57.63M50.87M37.55M38.73M47.95M49.22M41.35M35.37M38.89M27.32M24.04M19.39M22.3M50.18M40.2M
Operating Margin %9.78%8.46%6.61%5%2.97%5.04%4.91%4.92%5.72%5.61%6.56%7.4%7.8%9.14%8.97%10.2%8%7.61%5.93%6.48%8.52%9.07%7.92%7.48%8.49%6.5%5.2%4.4%5.05%10.83%10.41%
Operating Income Growth %-49.66%50.1%79.13%-37.37%5.75%-1.8%-12.55%3.63%-10.62%-9.81%-1.3%-5.65%5.63%-13.46%36.83%13.28%35.47%-3.03%-19.23%-2.58%19.02%16.93%-9.05%42.35%13.64%23.99%-13.06%-55.56%24.82%5.79%
EBITDA204.07M173.27M127.75M99.17M72.39M91.6M90.17M91.46M97.97M96.76M99.56M104.24M102.39M100.63M98.03M107.75M84.77M76.3M62.37M55.73M60.66M63.37M53.79M46.57M50.03M39.18M38.48M29.77M34.4M65.18M53.4M
EBITDA Margin %12.88%11.42%9.84%8.69%6.74%9.06%9.19%9.18%9.99%10.04%10.78%11.5%11.75%12.75%12.88%13.94%11.76%11.42%9.85%9.32%10.78%11.68%10.31%9.85%10.92%9.33%8.32%6.76%7.8%14.06%13.82%
EBITDA Growth %22.64%35.64%28.82%37%-20.97%1.58%-1.4%-6.65%1.25%-2.82%-4.48%1.8%1.76%2.65%-9.02%27.11%11.1%22.34%11.9%-8.12%-4.27%17.81%15.49%-6.92%27.69%1.82%29.25%-13.45%-47.22%22.05%0%
D&A (Non-Cash Add-back)49.13M44.92M41.98M42.03M40.49M40.67M42.02M42.42M41.89M42.65M39.02M37.11M34.38M28.55M29.79M28.9M27.14M25.43M24.82M17.01M12.71M14.15M12.44M11.21M11.15M11.87M14.44M10.38M12.1M15M13.2M
EBIT158.72M168.8M140.54M89.06M27.79M150.88M53.82M91.15M79.58M79.44M84.15M87.88M87.36M102.51M93.94M99.83M81.48M68.37M54.16M73.41M47.95M49.22M41.35M35.37M38.89M27.32M24.04M19.39M22.3M50.18M40.2M
Net Interest Income508K3.47M5.97M8.06M4.57M3.82M4.4M4.05M2.49M1.28M1.54M2.89M2.38M4.91M4.17M4.54M4.87M-716K-873K-1.17M00000000000
Interest Income8.6M9.84M10.1M8.38M5.13M4.67M5.79M7.19M7.18M6.17M5.48M5.49M4.55M5.24M4.62M4.98M5.38M00000000000000
Interest Expense8.09M6.37M4.13M324K563K845K1.4M3.13M4.7M4.89M3.94M2.61M2.17M331K455K443K513K716K873K1.17M00000000000
Other Income/Expense-4.3M34.08M50.65M31.6M-4.67M99.11M4.27M38.98M18.81M20.44M19.66M18.15M17.18M30.09M25.25M20.53M23.34M16.78M15.73M33.51M6.33M-2.53M-1.3M-2.08M-11.44M-5.16M-6.88M-5.35M-32.4M-12.98M-40.2M
Pretax Income150.64M162.43M136.41M88.74M27.23M150.04M52.42M88.02M74.88M74.55M80.21M85.27M85.19M102.18M93.48M99.38M80.97M67.66M53.29M72.23M54.28M46.69M40.05M33.29M27.45M22.16M17.16M14.04M-10.1M37.2M0
Pretax Margin %9.51%10.7%10.51%7.77%2.53%14.84%5.35%8.83%7.64%7.73%8.68%9.41%9.77%12.95%12.28%12.85%11.24%10.12%8.42%12.08%9.64%8.61%7.68%7.04%5.99%5.28%3.71%3.19%-2.29%8.03%-
Income Tax34.62M39.83M34.32M23.45M7.25M10.95M10.43M20.04M16.18M18.87M29.67M32.13M31.82M37.56M34.18M34.39M28.27M27.61M16.92M26.79M17.54M18.05M16.08M13.34M11.01M8.96M6.94M5.65M-3.7M200K0
Effective Tax Rate %22.98%24.52%25.16%26.43%26.64%7.3%19.9%22.77%21.61%25.31%36.99%37.68%37.36%36.76%36.56%34.61%34.92%40.8%31.75%37.08%32.31%38.67%40.15%40.06%40.11%40.44%40.45%40.27%36.63%0.54%-
Net Income114.66M120.02M101.93M66.8M22.45M138.59M41.87M68.21M58.96M56.2M50.54M53.14M53.37M64.61M59.3M64.99M52.7M40.05M36.37M45.45M36.74M28.64M23.97M19.95M16.44M13.2M10.22M8.38M-6.4M37M29.3M
Net Margin %7.24%7.91%7.85%5.85%2.09%13.71%4.27%6.85%6.01%5.83%5.47%5.86%6.12%8.19%7.79%8.4%7.31%5.99%5.74%7.6%6.53%5.28%4.59%4.22%3.59%3.14%2.21%1.9%-1.45%7.98%7.58%
Net Income Growth %13.25%17.75%52.59%197.61%-83.8%230.99%-38.62%15.68%4.91%11.21%-4.9%-0.42%-17.4%8.96%-8.76%23.33%31.58%10.11%-19.97%23.7%28.3%19.45%20.15%21.38%24.52%29.18%21.89%230.98%-117.3%26.28%38.86%
Net Income (Continuing)116.02M122.61M102.09M65.29M19.98M139.09M41.99M67.98M58.7M55.68M50.54M53.14M53.37M64.61M59.3M64.99M52.7M40.05M36.37M45.45M36.74M28.64M23.97M19.95M16.44M13.2M10.22M8.38M-6.4M37M29.3M
Discontinued Operations0000000000000000000000000000000
Minority Interest6.3M5.74M3M1.73M3.24M5.46M3.08M476K1.18M694K-40.02M00000000001.19M874K812K750K000700K800K800K
EPS (Diluted)7.187.676.534.341.458.992.724.443.873.693.323.203.143.873.573.963.222.312.113.362.850.241.951.651.371.130.890.73-0.583.582.97
EPS Growth %11.73%17.46%50.46%199.31%-83.87%230.51%-38.74%14.73%4.88%11.14%3.75%1.91%-18.86%8.4%-9.85%22.98%39.39%9.48%-37.2%17.89%1087.5%-87.69%18.18%20.44%21.24%26.97%21.92%225.86%-116.2%20.54%28.02%
EPS (Basic)-7.766.624.361.469.032.744.473.873.703.343.343.244.053.654.093.222.312.163.472.990.342.051.721.431.170.890.73-0.584.173.48
Diluted Shares Outstanding15.96M15.65M15.6M15.38M15.45M15.42M15.37M15.36M15.24M15.22M15.21M14.49M14.22M16.7M16.6M16.41M13.68M13.58M13.13M12.99M12.89M12.79M12.29M12.06M11.97M11.68M11.47M11.42M11.12M10.34M9.87M
Basic Shares Outstanding15.64M15.47M15.39M15.31M15.41M15.35M15.31M15.27M15.22M15.19M15.13M13.89M13.82M13.83M13.85M13.77M13.67M13.56M12.83M12.56M12.29M12.24M11.69M11.61M11.51M11.27M11.45M11.42M11.12M8.87M8.42M
Dividend Payout Ratio-32.25%36.27%53.24%154.17%23.11%76.24%45.75%50.59%50.24%51.04%39.68%35.05%27.04%52.02%24.55%28.05%33.73%31.74%21.49%22.07%23.47%-------56.76%59.73%

Key Metrics

Growth RegimeAccelerating
ProfitabilityStable
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Regulatory staffing mandate risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Revenue Momentum Accelerates on Census Recovery

NHC's revenue grew 8.8% YoY in 2026Q2, accelerating from 2.2% in 2026Q1, according to the latest quarterly report, suggesting sustained top-line momentum from occupancy gains and rate adjustments.

The sequential acceleration from 2.2% to 8.8% YoY growth indicates that the company is benefiting from both improved skilled mix and higher occupancy, as evidenced by the revenue step-up from $381.8M to $408.0M. This trend appears durable given the ongoing recovery in skilled nursing demand and the company's strategic expansion into behavioral health, which may provide additional growth avenues. However, investors should monitor whether this pace is sustainable as the base effects from prior-year disruptions fade.

Gross Margin Expansion Reflects Operating Discipline

Gross margin improved to 40.7% in 2026Q2, up from 38.4% a year earlier, as reported in the income statement, indicating effective cost management despite inflationary pressures on labor and supplies.

The 230 basis point year-over-year expansion in gross margin suggests that NHC is successfully passing through rate increases and optimizing its cost structure, likely through better labor utilization and a favorable payer mix. This margin resilience is notable given the industry-wide challenges of wage inflation and regulatory mandates. The company's owner-operator model, which insulates it from REIT rent escalators, appears to provide a structural cost advantage that supports margin stability.

Operating Leverage Amplifies Earnings Growth

Operating income surged 43.4% YoY in 2026Q2 to $48.9M, outpacing revenue growth of 8.8%, based on the latest financials, demonstrating significant operating leverage as fixed costs are spread over a larger revenue base.

The operating margin expanded from 9.1% in 2025Q2 to 12.0% in 2026Q2, a 290 basis point improvement, indicating that SG&A expenses are growing at a slower pace than revenue. This leverage is a direct result of high fixed costs in facility operations, where incremental revenue flows through to operating income at a higher rate. The company's ability to maintain SG&A at roughly $11.5M despite revenue growth suggests disciplined overhead management, which should continue to drive margin expansion if revenue growth persists.

Earnings Quality Boosted by Investment Gains

Net income of $40.3M in 2026Q2 includes significant non-operating gains from marketable securities, as per the financial statements, which may overstate core operating profitability and warrant adjustment for normalized earnings.

The net margin of 9.9% in 2026Q2 is higher than the operating margin of 12.0% would suggest, implying that non-operating income, likely from the company's investment portfolio, is contributing to net income. This is consistent with NHC's large holdings of marketable securities, which can create volatility in reported earnings. Analysts should strip out these investment gains to assess the underlying profitability of the healthcare operations, which appears to be improving but not as robust as the headline net income suggests.

Labor Costs Remain the Primary Margin Risk

COGS increased 6.9% YoY in 2026Q2, slightly below revenue growth, as reported in the income statement, but labor costs remain the most volatile expense line and could pressure margins if staffing mandates escalate.

The cost of goods sold, which includes facility-level labor and supplies, grew at a slower pace than revenue, indicating that management is effectively controlling direct costs. However, the proposed federal minimum staffing mandates for long-term care facilities could force NHC to increase nursing hours, potentially raising labor costs significantly. The company's reliance on agency staffing during labor shortages has historically caused margin compression, and any regulatory changes that exacerbate this could undermine the current margin stability.

2024Q4 Marked a Turning Point in Margin Recovery

The 2024Q4 quarter showed a sharp improvement in gross margin to 36.6% from 38.2% in 2024Q2, as per the income statement, signaling the start of a margin recovery driven by operational efficiencies and revenue growth.

In 2024Q4, revenue jumped 22.7% YoY to $369.4M, and gross margin expanded to 36.6%, up from 36.6% in the prior year, but more importantly, operating income rose to $26.6M from $15.6M in 2024Q1, indicating a step-change in profitability. This inflection appears to be driven by improved occupancy and skilled mix, as well as cost containment measures. The subsequent quarters have built on this momentum, with gross margins consistently above 39%, suggesting that the operational improvements are sustainable.

What Could Invalidate the Base Case

Despite strong recent growth, NHC's reliance on investment gains and potential regulatory staffing mandates could compress margins, as reported in the latest financials, challenging the sustainability of earnings growth.

The elevated net income in 2026Q2 may be overstated by non-operating investment gains, which are not core to healthcare operations and could reverse. Additionally, the proposed federal minimum staffing mandates could force significant labor cost increases, directly pressuring the gross margin that has been a key driver of the bull case. If occupancy gains plateau or skilled mix deteriorates, the operating leverage that amplified earnings could reverse, leading to margin compression and slower EPS growth.

NHC — Frequently Asked Questions

Quick answers to the most common questions about buying NHC stock.

What was National HealthCare Corporation's (NHC) revenue in 2025?

For fiscal year 2025, National HealthCare Corporation (NHC) reported total revenue of $1.52B. This represents a 292.9% increase compared to $386.3M in 1996.

Is National HealthCare Corporation (NHC) profitable?

National HealthCare Corporation (NHC) is profitable, generating $120.0M in net income for the fiscal year ending 2025 with a net profit margin of 7.9%.

What is National HealthCare Corporation's operating profit margin?

National HealthCare Corporation (NHC) reported an operating income of $128.4M, resulting in an operating profit margin of 8.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is National HealthCare Corporation's gross profit and gross margin?

National HealthCare Corporation (NHC) generated $596.7M in gross profit for the year, representing a gross profit margin of 39.3%. This demonstrates the company's core pricing power and production efficiency.